Barbell Medicine Podcast

They unpack how excess body fat and adipose signals suppress testosterone through aromatase, inflammation, and leptin-kisspeptin pathways. They explore sleep loss and undiagnosed sleep apnea as hidden drivers of low testosterone. They cover weight loss, GLP-1s, and bariatric surgery effects on testosterone. They discuss low energy availability in high-volume lifters and when replacement therapy crosses into performance enhancement.

They argue the novice/intermediate/advanced labels mislead and show why stalls are often just noise, not failure. They explain four adaptive systems (neural, muscle, tendon, bone) and how each follows different clocks. They review 17 years of powerlifting data and why strength slows smoothly. They cover practical diagnostics for stalled lifts and why early gains can mask tissue lag.

Austin Baraki, physician and sports-medicine clinician, breaks down how testosterone tests and physiology really work. He explains why most symptoms blamed on low T are from other causes. Short, clear takes on total vs free T, the role of SHBG, the saturation model, and what a proper diagnostic workup should include.

They unpack what happens when people stop GLP-1 medications and why most weight and metabolic gains drift back toward baseline. They compare drug durability to lifestyle-only trials and argue the benefits accumulate only while the drug is taken. They also cover lifting with osteopenia, practical strength protocols, and evidence from the LIFTMOR high-intensity training study.

They dig into why many men start testosterone treatment without blood tests and how one low lab value often corrects on repeat testing. They expose that many over‑the‑counter “boosters” are ineffective or contaminated. They analyze large studies and explain how testing methods and hidden measures of body fat can make a population decline look worse than it is.

A 43-year-old trainee develops severe muscle injury after starting exercise and new meds. They walk through the dramatic CK spike, how to tell exertional rhabdo from drug-related myopathy, and the three proposed muscle mechanisms linked to statins. Trials on statin side effects and nocebo effects get covered. Treatment options and alternative lipid-lowering drugs are discussed along with modern guideline changes.

Austin Baraki, an internist specializing in sports medicine and fatigue differentials, joins to unpack what people mean by 'overtrained'. He and Jordan clarify confusing terminology and review why biomarkers and wearables often mislead. They cover the main theories, practical monitoring (session RPE), common non-OTS causes of decline, and when medical evaluation makes sense.

A rapid AMA covering VO2 max versus broader cardiorespiratory fitness and why single-metric targets can mislead. They unpack current out-of-pocket costs for GLP-1 medications and how manufacturer programs change pricing. They challenge the 10,000-step myth, explore walking intensity versus volume, and offer practical trade-offs between steady walking and higher-intensity cardio.

They explain why waist measurements predict metabolic risk far better than the scale. They define visceral versus subcutaneous fat and review three theories linking visceral fat to disease. They cover how to measure waist correctly, waist-to-height thresholds, and a weight-to-waist guideline for tracking fat quality. They discuss why exercise cuts visceral fat more than diet, how GLP-1s and testosterone affect body composition, and practical measurement tips.

Dr. Austin Baraki, physician and clinical expert on lab interpretation, explains why elevated liver-associated enzymes often come from muscle. Short cases and clear rules unpack ALT/AST, GGT, timing of changes, and how pre-test exercise triggers false alarms. Practical advice on what labs to add and what to tell your clinician is presented in punchy, actionable segments.